Advertisement
Advertisement
U.S. markets open in 8 hours 56 minutes
Advertisement
Advertisement
Advertisement
Advertisement

electroCore, Inc. (ECOR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.6754+0.0004 (+0.06%)
At close: 04:00PM EST
0.6800 +0.00 (+0.68%)
After hours: 04:34PM EST
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    electroCore to Participate at Canaccord Genuity MedTech & Diagnostics Forum

    ROCKAWAY, NJ, Nov. 11, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will be available for virtual one-on-one meetings at the Canaccord Genuity MedTech & Diagnostics Forum. The conference is taking place virtually November 18, 2021. Details are as follows: Canaccord Genuity MedTech & Diagnostics Forum:Date: Thursday, November 18, 2021Event: One-on-one meetingsPlease contact y

  • Zacks Small Cap Research

    ECOR: Third Quarter Results

    By John Vandermosten, CFA NASDAQ:ECOR READ THE FULL ECOR RESEARCH REPORT Third Quarter 2021 Financial and Operational Results On November 4, 2021, electroCore Inc. (NASDAQ:ECOR) presented its third quarter 2021 financial and operational results in a press release and Form 10-Q filed with the SEC. A conference call with investors and analysts was held concurrent with the release. Third quarter

  • GlobeNewswire

    electroCore Announces Third Quarter 2021 Financial Results

    Third quarter 2021 revenue grew 17% sequentially and 38% over third quarter 2020 Company to host a conference call and webcast today, November 4, 2021 at 4:30 pm ET ROCKAWAY, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced third quarter 2021 financial results and provided an operational update. Third Quarter 2021 and Recent Highlights Revenue of $1.5 million, representing an increase of 17% sequentially

Advertisement
Advertisement